BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6196538)

  • 41. [The role of the complement system in the pathogenesis of yersinioses].
    Kudrina NV; Besednova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):41-4. PubMed ID: 9432845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seroepidemiologic study on the occurrence of antibodies against Yersinia enterocolitica and Yersinia pseudotuberculosis in urban and rural population of the Lublin region (eastern Poland).
    Stojek NM
    Ann Agric Environ Med; 1999; 6(1):57-61. PubMed ID: 10384217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of porin from the outer membrane of Yersinia pseudotuberculosis for serodiagnosis of pseudotuberculosis].
    Novikova OD; Portniagina OIu; Frolova GM; Solov'eva TF; Pavlova TN; Timchenko NF; Prokopenkova AP; Ovodov IuS
    Biull Eksp Biol Med; 1995 Aug; 120(8):199-202. PubMed ID: 7579285
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immune complexes and R-proteins in yersinioses].
    Besednova NN; Kudrina NV
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):45-9. PubMed ID: 9432846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trypsin-like proteinase and its endogenous inhibitor from Yersinia pseudotuberculosis. Biological activity.
    Burtseva TI; Loenko YN
    Biochemistry (Mosc); 1999 Sep; 64(9):986-9. PubMed ID: 10521713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Routes for the spread of the pseudotuberculosis microbe, Y. pseudotuberculosis, in infection foci].
    Kuznetsov VG
    Gig Sanit; 1980 Sep; (9):81-3. PubMed ID: 7000625
    [No Abstract]   [Full Text] [Related]  

  • 47. [Cellular reactions of increased delayed sensitivity in human pseudotuberculosis].
    Timchenko NF; Dzadzieva MF; Malyĭ VP; Khoroshko VA
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jan; (1):80-3. PubMed ID: 7043971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prophylaxis of the experimental pseudotuberculosis infection by immunization with porin from Yersinia pseudotuberculosis].
    Darmov IV; Marakulin IV; Pogorel'skiĭ IP; Novikova OD; Portniagina OIu; Solov'eva TF
    Biull Eksp Biol Med; 1999 Feb; 127(2):221-3. PubMed ID: 10095962
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pathomorphology of experimental pseudotuberculous (Yersinia) arthritis].
    Isachkova LM; Timchenko NF; Somov GP
    Arkh Patol; 1984; 46(5):69-74. PubMed ID: 6380461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Several outbreaks of Yersinia pseudotuberculosis in California turkey flocks.
    Wallner-Pendleton E; Cooper G
    Avian Dis; 1983; 27(2):524-6. PubMed ID: 6347170
    [No Abstract]   [Full Text] [Related]  

  • 51. [Change in phagocytic activity toward the agent of tularemia in highly sensitive animals with mixed infections].
    Dunaeva TN; Shlygina KN
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):86-91. PubMed ID: 325967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Contribution to the differentiation of cross-reacting antibodies in brucellosis serology--1. Reactions with various Yersinia serotypes and antibody avidity].
    Staak C; Draeger A; Bahn P; Nöckler K
    Berl Munch Tierarztl Wochenschr; 2000 Oct; 113(10):361-7. PubMed ID: 11084752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Reproduction of Brucella titers in swine using experimental infection with Yersinia enterocolitica, serotypes 0:9 and 0:6].
    Nattermann H; Horsch F; Zimmermann H
    Arch Exp Veterinarmed; 1980; 34(5):741-52. PubMed ID: 6779772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Yersinia-arthritis in childhood (author's transl)].
    Saule H; Würges U
    Monatsschr Kinderheilkd; 1981 Nov; 129(11):648-50. PubMed ID: 7033769
    [No Abstract]   [Full Text] [Related]  

  • 55. [Yersinia arthritis. frequency of enteral yersinias and their diagnosis (author's transl)].
    Knapp W
    MMW Munch Med Wochenschr; 1981 Dec; 123(49):1903-7. PubMed ID: 6796877
    [No Abstract]   [Full Text] [Related]  

  • 56. [Secondary immunodeficiency in Pseudotuberculosis in man and in experiment].
    Isachkova LM; Zhavoronkov AA
    Arkh Patol; 1991; 53(11):28-33. PubMed ID: 1799314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Modeling of pseudotuberculosis infection].
    Polotskiĭ IuE; Tseneva GIa; Efremov VE; Kleganov VK
    Tr Inst Im Pastera; 1983; 60():91-103. PubMed ID: 6367149
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies on aerosol Yersinia pseudotuberculosis infection of guinea-pigs.
    Velianov D; Nikolova S; Naĭdenski Kh; Raducheva T; Kŭsovski V; Grigoriev I; Ilieva L
    Acta Microbiol Bulg; 1993; 30():3-10. PubMed ID: 8285130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Epidemiological importance of Yersinia transmission routes and factors in pseudotuberculosis foci].
    Kuznetsov VG
    Voen Med Zh; 1981 Nov; (11):37-9. PubMed ID: 7032057
    [No Abstract]   [Full Text] [Related]  

  • 60. Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model.
    Kumar S; Balakrishna K; Agarwal GS; Merwyn S; Rai GP; Batra HV; Sardesai AA; Gowrishankar J
    Antonie Van Leeuwenhoek; 2009 Jan; 95(1):91-100. PubMed ID: 18985430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.